Evolving Market Trends In The Skin Cancer Diagnostics Industry: Advancements In Skin Cancer Diagnostics With The Launch Of PRAME Antibody

The Skin Cancer Diagnostics Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Expected Skin Cancer Diagnostics Market Size During the Forecast Period?
The market for diagnosing skin cancer has seen considerable expansion in the past few years. Its value is projected to increase from $3.13 billion in 2024 to $3.39 billion in 2025, maintaining a compound annual growth rate (CAGR) of 8.4%. The historic growth of this market can be linked to a heightened occurrence of skin cancer, an aging population, the rise in awareness and educational programs, as well as governmental efforts towards early detection.

There is an anticipated substantial surge in the skin cancer diagnostics market size over the coming years. With a projected compound annual growth rate (CAGR) of 8.4%, it is expected to expand to $4.69 billion by 2029. This growth can be credited to increased sun exposure consciousness, the adoption of personalized medicine strategies, the progress in telemedicine and remote observation, as well as the worldwide expansion of healthcare infrastructure. Dominant trends within the forecast period incorporate the assimilation of digital health platforms, advances in skin cancer medications, cross-disciplinary methodologies, advancements in dermatopathology, and strides made in patient education and awareness.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11914

What Are the High-Growth Segments in the Skin Cancer Diagnostics Market?
The skin cancer diagnostics market covered in this report is segmented -

1) By Cancer Type: Basal Cell Carcinoma, Squamous Cell Carcinoma, Malignant Melanoma, Other Cancer Types
2) By Type: Diagnosis, Therapeutics
3) By Application: Hospital, Clinic, Laboratory, Other Applications

Subsegments:
1) By Basal Cell Carcinoma: Diagnostic imaging Techniques, Biopsy Procedures, Molecular Diagnostic Tests
2) By Squamous Cell Carcinoma: Diagnostic imaging Techniques, Biopsy Procedures, Molecular Diagnostic Tests
3) By Malignant Melanoma: Diagnostic Imaging Techniques, Biopsy Procedures, Molecular Diagnostic Tests
4) By Other Cancer Types: Non-Melanoma Skin Cancers, Dermatofibrosarcoma Protuberans, Merkel Cell Carcinoma

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11914&type=smp

What Key Drivers Are Expected to Influence Future Skin Cancer Diagnostics Market Growth?
The rise in melanoma cases is predicted to fuel the skin cancer diagnostics market's expansion. Melanoma, a skin cancer variant, originates in melanin-producing cells, responsible for the skin, hair, and eye color. It's vital to recognize and classify skin lesions through skin cancer diagnostics, which supports timely detection, precise diagnosis, and efficient skin cancer treatment plans. As per a report released in 2023 by the American Cancer Society Inc., a nationally based voluntary health organization in the U.S. striving to eradicate cancer, the number of males afflicted with melanoma increased from 57,180 in 2022 to 58,120 in 2023. Moreover, data from the American Society of Clinical Oncology in March 2023, a professional organization in the U.S that represents all oncology physicians, reveals that melanoma comprises about 1% of all diagnosed skin cancers in the country. However, it causes the majority of skin cancer deaths. It's projected that melanoma will result in 7,990 deaths in the U.S. in 2023 (5,420 males and 2,570 females). As such, the escalation in melanoma cases is propelling the growth of the skin cancer diagnostics market.

Which Companies Hold the Largest Share Across Different Skin Cancer Diagnostics Market Segments?
Major companies operating in the skin cancer diagnostics market include Pfizer Inc., F. Hoffmann-La Roche Limited, Merck & Co., Bayer AG, Novartis AG, Bristol-Myers Squibb Company, Sanofi, Eli Lilly and Company, Canon Medical Systems Corporation, Amgen Inc., GE Healthcare, Daiichi Sankyo Company Limited., National Cancer Institute, Agilent Technologies Inc., bioMerieux SA, Teva Pharmaceutical Industries, Bruker Corp, Almirall, Genentech, Castle Biosciences, Sun Pharmaceutical Industries Limited., American Academy of Dermatology, Biolitec Ag, Alma Lasers, DermTech Inc., SkylineDx BV, DermLite LLC, AMLo Biosciences Limited

What Trends Are Driving Growth in The Skin Cancer Diagnostics Market?
Prominent corporations in the skin cancer diagnostics market are concentrating their efforts on creating new products, such as the PRAME protein, to improve the diagnosis and treatment methods for melanoma and other types of skin cancer. PRAME, or Preferentially Expressed Antigen in Melanoma, is a cancer/testis antigen with promising capabilities in melanoma diagnostics. To illustrate, in October 2022, Roche, a global healthcare firm based in Switzerland, unveiled the PRAME (EPR20330) Antibody. This melanoma-associated antigen specializes in identifying PRAME protein expression in tissue samples from individuals who may have melanoma. The antibody plays an essential role in differentiating between benign and malignant lesions. Confirming PRAME expression indicates malignancy, a crucial step for correct diagnosis and treatment planning.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/skin-cancer-diagnostics-global-market-report

What Are the Emerging Geographies for The Skin Cancer Diagnostics Market Growth?
North America was the largest region in the skin cancer diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the skin cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Skin Cancer Diagnostics Market?
2. What is the CAGR expected in the Skin Cancer Diagnostics Market?
3. What Are the Key Innovations Transforming the Skin Cancer Diagnostics Industry?
4. Which Region Is Leading the Skin Cancer Diagnostics Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.